These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34654789)

  • 1. Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension.
    Adie SK; Abdul-Aziz AA; Ketcham SW; Moles VM
    J Cardiovasc Pharmacol; 2022 Jan; 79(1):e11-e17. PubMed ID: 34654789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary artery pulsatility index predicts prolonged inotrope/pulmonary vasodilator use after implantation of continuous flow left ventricular assist device.
    Aggarwal V; Tume SC; Rodriguez M; Adachi I; Cabrera AG; Tunuguntla H; Qureshi AM
    Congenit Heart Dis; 2019 Nov; 14(6):1130-1137. PubMed ID: 31802608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Importance of Baseline and Longitudinal Evaluation in the Follow-Up of Vasodilator Therapy in Pulmonary Arterial Hypertension.
    Wright L; Dwyer N; Wahi S; Marwick TH
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2103-2111. PubMed ID: 30343091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of β-Blockers in Pulmonary Hypertension.
    Perros F; de Man FS; Bogaard HJ; Antigny F; Simonneau G; Bonnet S; Provencher S; Galiè N; Humbert M
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.
    Ishihara S; Gayat E; Sato N; Arrigo M; Laribi S; Legrand M; Placido R; Manivet P; Cohen-Solal A; Abraham WT; Jessup M; Mebazaa A
    Clin Res Cardiol; 2016 Dec; 105(12):971-980. PubMed ID: 27314418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension.
    Narechania S; Torbic H; Tonelli AR
    J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):131-141. PubMed ID: 31594400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
    Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
    Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
    Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease.
    Chida-Nagai A; Sagawa K; Tsujioka T; Fujimoto T; Taniguchi K; Sasaki O; Izumi G; Yamazawa H; Masaki N; Manabe A; Takeda A
    Heart Vessels; 2020 Sep; 35(9):1307-1315. PubMed ID: 32285188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.
    van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS
    Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.
    Antigny F; Mercier O; Humbert M; Sabourin J
    Arch Cardiovasc Dis; 2020 Jan; 113(1):70-84. PubMed ID: 31924541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experts consensus on the management of the right heart function in critically ill patients].
    Wang XT; Liu DW; Zhang HM; Long Y; Guan XD; Qiu HB; Yu KJ; Yan J; Zhao H; Tang YQ; Ding X; Ma XC; Du W; Kang Y; Tang B; Ai YH; He HW; Chen DC; Chen H; Chai WZ; Zhou X; Cui N; Wang H; Rui X; Hu ZJ; Li JG; Xu Y; Yang Y; Ouyan B; Lin HY; Li YM; Wan XY; Yang RL; Qin YZ; Chao YG; Xie ZY; Sun RH; He ZY; Wang DF; Huang QQ; Jiang DP; Cao XY; Yu RG; Wang X; Chen XK; Wu JF; Zhang LN; Yin MG; Liu LX; Li SW; Chen ZJ; Luo Z;
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):962-973. PubMed ID: 29202543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and course of pulmonary hypertension and right ventricular dysfunction in patients undergoing orthotopic heart transplantation.
    Bozbaş H; Karaçağlar E; Ozkan M; Bozbaş SS; Eyüboğlu FÖ; Sade E; Altin C; Polat E; Sezgin A; Müderrisoğlu H
    Transplant Proc; 2013; 45(10):3538-41. PubMed ID: 24314953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical care of patients with pulmonary arterial hypertension.
    Aryal S; King CS
    Curr Opin Pulm Med; 2020 Sep; 26(5):414-421. PubMed ID: 32740380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of pulmonary arterial hypertension in Korea.
    Jang AY; Chung WJ
    Korean J Intern Med; 2019 Jul; 34(4):696-707. PubMed ID: 31272141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update.
    Coons JC; Pogue K; Kolodziej AR; Hirsch GA; George MP
    Curr Cardiol Rep; 2019 Nov; 21(11):141. PubMed ID: 31758342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right Ventricle-Specific Three-Dimensional Wall Motion Tracking for Visualization of Regional Wall Motion Abnormality in Patients With Pulmonary Arterial Hypertension.
    Moriyama H; Murata M; Kataoka M; Kawakami T; Endo J; Kohno T; Itabashi Y; Seo Y; Iwao Y; Fukuda K
    Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008795. PubMed ID: 30939920
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.